15 Recruiting Studies Using Ixazomib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Ixazomib
Ixazomib + Pomalidomide + Dexamethasone In MM
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Urothelial Carcinoma
View Study & Checklist ➔Ixazomib Maintenance Study in Patients With AL Amyloidosis
📍 Tufts Medical Center — Boston, Massachusetts
AL Amyloidosis
View Study & Checklist ➔Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
📍 University of California San Diego — La Jolla, California
Myeloma
View Study & Checklist ➔Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
📍 Northern Light Eastern Maine Medical Center — Bangor, Maine
Myeloma, Multiple
View Study & Checklist ➔Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
📍 Boston Medical Center — Boston, Massachusetts
AL Amyloidosis
View Study & Checklist ➔Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Chronic Lymphocytic Leukemia
View Study & Checklist ➔Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Plasma Cell Myeloma
View Study & Checklist ➔Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Newly Diagnosed Multiple Myeloma
View Study & Checklist ➔Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent AL Amyloidosis
View Study & Checklist ➔PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
📍 Children's Hospital Los Angeles — Los Angeles, California
ALL, Childhood
View Study & Checklist ➔Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
📍 City of Hope — Duarte, California
Multiple Myeloma
View Study & Checklist ➔Selinexor and Backbone Treatments of Multiple Myeloma Patients
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Multiple Myeloma
View Study & Checklist ➔Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
📍 Emory Winship Cancer Institute — Atlanta, Georgia
Haematological Malignancy
View Study & Checklist ➔Trial of Ixazomib for Kaposi Sarcoma
📍 UC San Diego — San Diego, California
Kaposi Sarcoma
View Study & Checklist ➔